Biostate AI closes $12M to bring the Netflix model to molecular diagnostics
Posted:
Biostate AI, a leading innovator in artificial intelligence and RNA sequencing, announced the successful completion of a $12M Series A funding round, led by Accel. The company’s immediate focus is revolutionizing RNAseq accessibility and developing clinically relevant predictive models.
More patients are getting the right treatment in the right place more quickly leading to better outcomes following a stroke thanks to a four-year collaborative programme led by Health Innovation Oxford and Thames Valley (HIOTV) supporting the deployment of artificial…
UCL GBSH has been featured in @OpenAI Academy for the pioneering use of generative AI in teaching digital health. Congratulations from the GIANT team for being recognised globally for preparing future leaders at the frontier of AI + healthcare.
Read more here.
Attendees
Sponsors and Exhibitors
Agenda 2025
Contact us